2023
DOI: 10.1016/j.focha.2023.100229
|View full text |Cite
|
Sign up to set email alerts
|

Potential of the endogenous and artificially inserted CRISPR-Cas system for controlling virulence and antimicrobial resistance of food pathogens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 112 publications
0
2
0
Order By: Relevance
“…Verified the variation in the reduction of mobility that exists in flagellum phenotypes [123] Costigan et al ( 2022) were able to validate the repression of the astA gen which encodes for arilsulfatase using the CRISPR interference (CRISPRi) in Campylobacter jejuni [122]. The same tool was applied to a deleted M1Cam strain showing that the Cas9 endogenous system did not affect the CRISPRi system.…”
Section: Crispr-dcas9mentioning
confidence: 99%
See 1 more Smart Citation
“…Verified the variation in the reduction of mobility that exists in flagellum phenotypes [123] Costigan et al ( 2022) were able to validate the repression of the astA gen which encodes for arilsulfatase using the CRISPR interference (CRISPRi) in Campylobacter jejuni [122]. The same tool was applied to a deleted M1Cam strain showing that the Cas9 endogenous system did not affect the CRISPRi system.…”
Section: Crispr-dcas9mentioning
confidence: 99%
“…Cas9 from C. jejuni is toxic to human cells, so the C. jejuni Cas9 gene, transcript and protein are a perfect target to control or regulate the infectious processes caused by this bacterium. For Campylobacter, as well as for other bacteria, once confirmed that it carries a CRISPR-Cas9 type system, it is recommended that, in addition to using other combined CRISPR systems of the type Cas3, dCas9, Cas13a, dCas13 or others, all this is used for the system to be effective (Figure 2) [123]. Like S. typhi, C. jejuni expresses genes from the LuxS family [119,120]; therefore, it is also considered a good target to develop CRISPR-type regulation tools.…”
Section: Crispr-dcas9mentioning
confidence: 99%